Ben Ward - Author for 24/7 Wall St.
Lastest Stories by Ben Ward
Private equity fund Ares Management has increased its stake again in out-of-home advertising firm Clear Channel Outdoor.
Published:
Fintel has begun to cover the stock of the largest non-bank loan servicer in the United States.
Published:
A rally has pushed shares of aerospace and electronics corporation Atronics to levels not seen since mid-2021.
Published:
The DiamondHead CEO and board chair has bought more stock in the blank check company ahead of its planned merger with Great Southern Homes.
Published:
A spike of investor sentiment followed a bullish fourth-quarter guidance update with a twist from Aterian's co-founder and CEO.
Published:
Veris Residential’s board has been busy again in discussions, this time with shareholder Madison International Realty.
Published:
Shares of biotech Zymeworks rallied after the market found out that the largest shareholder bought more shares in the company.
Published:
U.S. fourth quarter earnings season kicked off last week with major retail banks reporting figures and providing an updated picture on how the economy is tracking through the inflationary rate hiking...
Published:
Mattress manufacturer Purple Innovation has announced that its special committee board rejected the takeover proposal from insider shareholder Coliseum Capital.
Published:
Clover Health traded higher after the company provided a business update to investors that included some financial guidance for 2023.
Published:
Tilray Brands' share price slipped after reporting a lackluster second-quarter results.
Published:
The top 10 stocks with the highest Fintel insider sentiment score were primarily by small-cap biopharma stocks that have suffered some of the largest losses over 2022.
Published:
Shares of small-cap biotech firm Xeris slipped to fresh new lows even with a positive outlook update from management.
Published:
SSD2 LLC has disclosed a stake of 18.05% in Gelesis Holdings.
Published:
Steven Cohen's hedge fund Point72 had disclosed a 5.3% stake in lung disease focused biopharma company Plumonx.
Published: